Quantcast

Latest Fentanyl Stories

2014-08-19 12:28:53

NEWARK, Calif., Aug. 19, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation lawsuit against Actavis, Inc. related to Actavis's Abbreviated New Drug Application for generic versions of Depomed's Gralise(®) (gabapentin) tablets for the management of postherpetic neuralgia. Judge Pisano's ruling finds that Actavis infringes all...

2014-08-18 12:27:28

Announces Government Action to Enhance Safe Use of Opioids OTTAWA, Aug. 18, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health delivered a keynote address at the 147(th) Canadian Medical Association (CMA), General Council Meeting. During her remarks, the Minister affirmed the Government's commitment to continue working with the CMA on issues of importance while highlighting several themes encompassing some of her priorities, such as patient safety, prescription drug abuse, family...

2014-08-18 12:25:11

WASHINGTON, Aug. 18, 2014 /PRNewswire-USNewswire/ -- Emergency physicians should expect "an upswing in what on the surface appear to be heroin overdoses," but are actually overdoses tied to acetyl fentanyl, an opiate that is mixed into street drugs marketed as heroin. The looming threat of another unregulated quasi-legal drug is detailed today online in Annals of Emergency Medicine ("The Potential Threat of Acetyl Fentanyl: Legal Issues, Contaminated Heroin, and Acetyl Fentanyl...

2014-08-11 16:27:34

REDWOOD CITY, Calif., Aug. 11, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2014. On July 25, 2014, AcelRx announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company's new...

2014-08-07 16:29:04

CUPERTINO, Calif., Aug. 7, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the second quarter of 2014. Total revenues were $4.6 million and net loss was $5.5 million for the three months ended June 30, 2014 as compared to total revenues of $3.9 million and net loss of $5.1 million for the three months ended June 30, 2013. http://photos.prnewswire.com/prnvar/20020717/DRRXLOGO At June 30, 2014, we had cash and investments of $37.3 million, compared...

2014-08-04 16:26:29

NEWARK, Calif., Aug. 4, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced the appointment of R. Scott Shively, as Chief Commercial Officer and Senior Vice President. Mr. Shively has extensive commercial leadership experience in sales and marketing of pain and neurology products, for both specialty as well as larger pharmaceutical companies. Mr. Shively served as Executive Vice President and Chief Commercial Officer of Zogenix from November 2012 through August...

2014-07-30 16:29:50

CUPERTINO, Calif., July 30, 2014 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2014 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, August 7, 2014 at 4:30 pm Eastern Time (1:30 pm Pacific Time). http://photos.prnewswire.com/prnvar/20020717/DRRXLOGO A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2014-07-29 08:31:39

MELBOURNE, Australia, July 29, 2014 /PRNewswire/ -- -- Next phase of the TPM®/Oxymorphone clinical development program has commenced -- TPM®/Oxycodone Phase 2a trial to be conducted in Australia during Q4 2014 -- TPM®/Oxymorphone Phase 2 trial to be conducted in the United States in 1H 2015 Australian drug delivery company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today provided updates on its opioid transdermal patch programs after its...

2014-07-25 16:23:01

NEWARK, Calif., July 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release second quarter fiscal year 2014 financial results after the market closes on Wednesday, August 6, 2014. The Company will host a conference call beginning at 4:30 pm EDT, 1:30 pm PDT to discuss its results. Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on...

2014-07-23 08:32:46

WASHINGTON, July 23, 2014 /PRNewswire-USNewswire/ -- For critically ill patients arriving at the emergency department, the drug ketamine can safely provide analgesia, sedation and amnesia for rapid, life-saving intubation, despite decades-old studies that suggested it raised intracranial pressure. The results of a systematic review of 10 recent studies of what many emergency physicians regard as a "wonder drug" are published online today in Annals of Emergency Medicine ("The Effect...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related